Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells

Simon A Fox1, Alex K Richards, Ivonne Kusumah

  • 1Molecular Pharmacology Laboratory, School of Pharmacy, Curtin Health Innovation Research Institute, Curtin University, Bentley, WA, Australia.

Insights

Altered Wnt signaling molecules are found in malignant mesothelioma (MM), an aggressive cancer. Targeting Wnt/β-catenin pathways may offer new treatments for MM proliferation and drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Malignant mesothelioma (MM) is an aggressive cancer linked to asbestos exposure.
  • The role of Wnt signaling in MM has not been extensively studied.
  • Current treatments for MM remain a significant clinical challenge.

Purpose of the Study:

  • To investigate the expression of Wnt signaling pathway components in MM.
  • To determine the functional impact of Wnt signaling on MM cell behavior.
  • To explore therapeutic strategies targeting the Wnt pathway in MM.

Main Methods:

  • Surveyed Wnt pathway molecule expression in MM cell lines and primary mesothelial cells.
  • Assessed MM cell response to exogenous Wnt ligands and inhibitors.
  • Investigated the effect of targeting β-catenin on MM cell sensitivity to chemotherapy.

Main Results:

  • Frequent expression of Wnt3 and Wnt5a, and Fzd 2, 4, 6 observed.
  • Downregulation of Wnt4, Fzd3, sFRP4, APC, and axin2 in MM cells compared to mesothelial cells.
  • Wnt3a promoted MM proliferation, sFRP4 inhibited it, and targeting β-catenin sensitized MM cells to cytotoxic drugs.

Conclusions:

  • Evidence of altered Wnt/Fzd signaling molecule expression in MM.
  • Wnt pathway modulation presents a potential therapeutic avenue for MM.
  • Targeting Wnt signaling may overcome proliferation and drug resistance in malignant mesothelioma.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...